Nilotinib | High-Quality Pharmaceutical Reference Standard
Nilotinib is a selective tyrosine kinase inhibitor used in the treatment of Philadelphia chromosome–positive chronic myeloid leukemia (Ph+ CML). It works by inhibiting BCR-ABL kinase, reducing proliferation of malignant cells. Nilotinib API is manufactured under GMP-compliant conditions and is suitable for oral solid dosage formulations, including tablets.
Nilotinib API is manufactured and supplied by Artis Biotech | ASTANDARDS, ensuring high purity, consistent quality, and regulatory-compliant specifications. Our APIs are produced using validated processes and are suitable for research, development, and pharmaceutical manufacturing applications.
Total Products : 7
